Available in 10 mg and 20 mg vials, in lyophilized form.
Tesamorelin is a synthetic analogue of human growth hormone-releasing hormone (GHRH), comprising the 44-amino-acid GHRH sequence with a trans-3-hexenoyl group attached at the N-terminus. The modification confers resistance to enzymatic degradation.
Tesamorelin acts at the GHRH receptor on pituitary somatotrophs. Published research examines its effect on pulsatile growth hormone secretion, downstream IGF-1 expression, and visceral adipose tissue endpoints across preclinical and clinical study literature.
Areas of published research
- Growth hormone pulse amplitude and frequency following GHRH receptor activation
- Downstream IGF-1 expression as a marker of growth hormone axis activity
- Visceral adipose tissue measured by CT imaging in clinical study literature
- Lipid and metabolic parameters including triglycerides in preclinical and clinical research
For research use only. Not for human or veterinary use. Not a drug, food, or cosmetic.


Reviews
There are no reviews yet.